Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 34,444 $ 85,451
Marketable securities, current 70,544 39,633
Prepaid expenses 3,727 2,318
Grants revenue receivable 9,441 7,100
Accounts receivable, related party 1,300 408
In-process research and development - held for sale 4,500 4,500
Other current assets 242 489
Total current assets 124,198 139,899
Marketable securities, non-current 3,010 1,510
Operating lease right-of-use assets, non-current 9,617 9,959
Property and equipment, net 19,301 18,158
Other assets 4,617 4,676
Total assets 160,743 174,202
Current liabilities:    
Accounts payable 1,770 1,465
Accrued liabilities 11,531 14,544
Deferred revenue, current 11,465 8,511
Deferred revenue, current, related party 8,773 8,780
Other current liabilities, related party 7,754 0
Other current liabilities 2,543 2,501
Total current liabilities 43,836 35,801
Deferred revenue, long-term 14,523 18,944
Deferred revenue, long-term, related party 1,355 441
Long-term debt, net 2,888 2,940
Operating lease liabilities, non-current 11,232 11,682
Other liabilities 3,143 1,366
Total liabilities 76,977 71,174
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at March 31, 2020 and December 31, 2019; issued and outstanding: 250 shares at March 31, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares; issued and outstanding: 45,703,934 shares at March 31, 2020 and 45,589,157 shares at December 31, 2019 46 46
Additional paid-in capital 269,581 267,089
Accumulated other comprehensive income 282 18
Accumulated deficit (186,143) (164,125)
Total stockholders’ equity 83,766 103,028
Total liabilities and stockholders’ equity $ 160,743 $ 174,202